References
- Alangaden GJ, Thyagarajan R, Gruber SA, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant. 2006;20(4):401–409.
- Blazquez-Navarro A, Dang-Heine C, Wittenbrink N, et al. BKV, CMV, and EBV interactions and their effect on graft function one year post-renal transplantation: results from a large multi-centre study. EBioMedicine. 2018;34:113–121.
- Neild G, Anderson M, Hawes S, et al. Parvovirus infection after renal transplant. Lancet Lond Engl. 1986;328(8517):1226–1227.
- Hai An HP, Diem HT, Cuong NT. Parvovirus B19-associated anemia in kidney transplant recipients: a single-center experience. Transplant Proc. 2019;51(8):2693–2696.
- Rosado-Canto R, Carrillo-Pérez DL, Jiménez JV, et al. Treatment strategies and outcome of parvovirus B19 infection in kidney transplant recipients: a case series and litterature review of 128 patients. Rev Investig Clin Organo Hosp Enfermedades Nutr. 2019;71(4):265–274.
- Baek CH, Kim H, Yang WS, et al. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients. Transpl Infect Dis. 2017;19(5):e12754.
- Pabisiak K, Stępniewska J, Ciechanowski K. Pure red cell aplasia after kidney transplantation: parvovirus B19 culprit or coincidence? Ann Transplant. 2019;24:123–131.
- Liefeldt L, Buhl M, Schweickert B, et al. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant. 2002;17(10):1840–1842.
- Kelly HA, Siebert D, Hammond R, et al. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect. 2000;124(3):449–457.
- Mortimer PP, Luban NL, Kelleher JF, et al. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet. 1983;2(8348):482–484.
- Gallinella G, Manaresi E, Venturoli S, et al. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients. Eur J Clin Microbiol Infect Dis. 1999;18(11):811–813.
- Ki C-S, Kim I-S, Kim J-W, et al. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant. 2005;19(6):751–755.
- Park JB, Kim D-J, Woo S-Y, et al. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study. Transpl Int off J Eur Soc Organ Transplant. 2009;22(4):455–462.
- Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43(1):40–48.
- Hashizume H, Kageyama R. Hypocomplementemia is a diagnostic clue for parvovirus B19 infection in adults. J Dermatol. 2017;44(3):e27.
- Ieiri N, Hotta O, Taguma Y. Characteristics of acute glomerulonephritis associated with human parvovirus B19 infection. Clin Nephrol. 2005;64(4):249–257.
- Eid AJ, Chen SF, AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:201–205.
- Wong TY, Chan PK, Leung CB, et al. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis off J Natl Kidney Found. 1999;34(6):1132–1136.
- Zachary AA, Montgomery RA, Locke JE, et al. Proinflammatory events and HLA antibodies. Am J Transplant off J Am Soc Transplant Am Soc Transpl Surg. 2010;10(4):956.
- Locke JE, Zachary AA, Warren DS, et al. Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant off J Am Soc Transplant Am Soc Transpl Surg. 2009;9(9):2136–2139.
- Ravindranath MH, Terasaki PI, Pham T, et al. Therapeutic preparations of IVIg contain naturally occurring anti-HLA-E antibodies that react with HLA-Ia (HLA-A/-B/-Cw) alleles. Blood. 2013;121(11):2013–2028.
- Zachary AA, Lucas DP, Detrick B, et al. Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol. 2009;70(7):496–501.
- Cavallo R, Merlino C, Re D, et al. B19 virus infection in renal transplant recipients. J Clin Virol off Publ Pan Am Soc Clin Virol. 2003;26(3):361–368.
- Moudgil A, Nast CC, Bagga A, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001;59(6):2126–2133.
- Komatsuda A, Ohtani H, Nimura T, et al. Endocapillary proliferative glomerulonephritis in a patient with parvovirus B19 infection. Am J Kidney Dis. 2000;36(4):851–854.